Safety, Tolerance, and Pharmacokinetics of High-Dose Liposomal Amphotericin B (AmBisome) in Patients Infected with Aspergillus Species and Other Filamentous Fungi: Maximum Tolerated Dose Study

We conducted a phase I-II study of the safety, tolerance, and plasma pharmacokinetics of liposomal amphotericin B (L-AMB; AmBisome) in order to determine its maximally tolerated dosage (MTD) in patients with infections due to Aspergillus spp. and other filamentous fungi. Dosage cohorts consisted of...

Full description

Bibliographic Details

Published in:	Antimicrob Agents Chemother
Main Authors:	Walsh, Thomas J., Goodman, Jesse L., Pappas, Peter, Bekersky, Ihor, Buell, Donald N., Roden, Maureen, Barrett, John, Anaissie, Elias J.
Format:	Artigo
Language:	Inglês
Published:	American Society for Microbiology (ASM) 2001
Subjects:	Pharmacology
Online Access:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90858/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11709329/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.12.3487-3496.2001
Tags:	Add Tag No Tags, Be the first to tag this record!